Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT06429761

1 development in the corpus

NCT06429761

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 11, 2026 · PHASE 4 TRIAL

Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients

ClinicalTrials.gov

Registry record for an active Phase 4 safety study with no results posted; enrollment is complete but outcome data are not yet reported.

PreliminaryTrastuzumab deruxtecan NCT06429761 Breast Cancer

Reported

Planned enrollment100

Study phasePhase 4

Primary outcome measureSafety of trastuzumab deruxtecan in adult I…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support